title: Serotype distribution and drug resistance in Streptococcus pneumoniae, Palestinian Territories.
abstract: To determine antimicrobial drug resistance of Streptococcus pneumoniae serotypes, we analyzed isolates from blood cultures of sick children residing in the West Bank before initiation of pneumococcal vaccination. Of 120 serotypes isolated, 50.8%, 73.3%, and 80.8% of the bacteremia cases could have been prevented by pneumococcal conjugate vaccines. Serotype 14 was the most drug-resistant serotype isolated.
authors.affiliation: Caritas Baby Hospital, Bethlehem, Palestinian Territories, West Bank.
authors.forename: Randa
authors.initials: R
authors.lastname: Kattan
authors.forename: Amal
authors.initials: A
authors.lastname: Abu Rayyan
authors.forename: Inas
authors.initials: I
authors.lastname: Zheiman
authors.forename: Suzan
authors.initials: S
authors.lastname: Idkeidek
authors.forename: Sabri
authors.initials: S
authors.lastname: Baraghithi
authors.forename: Nabeel
authors.initials: N
authors.lastname: Rishmawi
authors.forename: Sultan
authors.initials: S
authors.lastname: Turkuman
authors.forename: Afaf
authors.initials: A
authors.lastname: Abu-Diab
authors.forename: Riyad
authors.initials: R
authors.lastname: Ghneim
authors.forename: Madeleine
authors.initials: M
authors.lastname: Zoughbi
authors.forename: Rula
authors.initials: R
authors.lastname: Dauodi
authors.forename: Raed
authors.initials: R
authors.lastname: Ghneim
authors.forename: Abed-El-Razeq
authors.initials: AE
authors.lastname: Issa
authors.forename: Issa
authors.initials: I
authors.lastname: Siryani
authors.forename: Randa
authors.initials: R
authors.lastname: Al Qas
authors.forename: Rawan
authors.initials: R
authors.lastname: Liddawi
authors.forename: Hatem
authors.initials: H
authors.lastname: Khamash
authors.forename: Moein
authors.initials: M
authors.lastname: Kanaan
authors.forename: Hiyam
authors.initials: H
authors.lastname: Marzouqa
authors.forename: Musa Y
authors.initials: MY
authors.lastname: Hindiyeh
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D001769:Blood / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D003470:Culture Media; D024881:Drug Resistance, Bacterial; D005260:Female; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008826:Microbial Sensitivity Tests; D008877:Middle East / Q000453:epidemiology; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000008:administration & dosage; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000187:drug effects* / Q000276:immunology / Q000302:isolation & purification; D014611:Vaccination
chemical_list: D000900:Anti-Bacterial Agents; D003470:Culture Media; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022242:Pneumococcal Vaccines